Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Seaman, D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07960407
ABSTRACT:
The invention relates to the essentially pure Λ/-[({2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl}amino)carbonyl]-4-methylbenzenesulfonamide Polymorph Forms A and B and to processes for the preparation of, compositions containing and to the uses of, such crystal forms.
REFERENCES:
patent: 02/32422 (2002-04-01), None
patent: WO 0232900 (2002-04-01), None
Caira, M.R., Topics in Current Chemistry, vol. 198, p. 163-208, “Crystalline Polymorphism of Organic Compounds.”
Haruta Naoaki
Kato Tomoki
Li Zheng Jane
Numata Toyoharu
Trask Andrew Vincent
Rahmani Niloofar
Requalia Pharma Inc.
Scully , Scott, Murphy & Presser, P.C.
Seaman D.
LandOfFree
Crystal forms of an imidazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal forms of an imidazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal forms of an imidazole derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2636388